San Francisco, CA, United States of America

Mary Maxon


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 21(Granted Patents)


Location History:

  • Somerville, MA (US) (2005)
  • San Francisco, CA (US) (2005 - 2007)

Company Filing History:


Years Active: 2005-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Mary Maxon

Introduction

Mary Maxon is a prominent inventor based in San Francisco, California. With an impressive portfolio of three patents, her work primarily focuses on enhancing the production of secondary metabolites in fungi, which has significant implications for various biotechnological applications.

Latest Patents

One of Mary Maxon's latest patents is titled "Modulation of Secondary Metabolite Production by Zinc Binuclear Cluster Proteins." This invention describes methods for improving the production of secondary metabolites by fungi through techniques such as increasing the expression of the LYS14 gene. Additionally, her patent on "Methods for Improving Secondary Metabolite Production in Fungi" delves into the enhancement of commercially important secondary metabolite production by modulating the expression of genes involved in this regulatory process. These innovative methods are essential for advancing the field of biotechnology.

Career Highlights

Mary has contributed her expertise to companies like Microbia, Inc. and Cytokinetics, Inc. Her experience in these organizations has played a vital role in her development as a leading inventor in her field.

Collaborations

Throughout her career, Mary Maxon has collaborated with various professionals, including colleagues Kevin T Madden and Amir Sherman. These partnerships have enriched her innovative endeavors and contributed to her success in patenting her groundbreaking work.

Conclusion

Mary Maxon's inventive spirit and dedication to enhancing fungal secondary metabolite production underscore her significant contributions to biotechnology. Her patents not only reflect her creativity but also pave the way for advancements that could benefit several industries reliant on these metabolites.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…